GenMark Diagnostics Debt to Equity Ratio 2010-2019 | GNMK

Current and historical debt to equity ratio values for GenMark Diagnostics (GNMK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GenMark Diagnostics debt/equity for the three months ending September 30, 2019 was 6.40.
GenMark Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.06B $0.01B 6.40
2019-06-30 $0.06B $0.02B 3.70
2019-03-31 $0.05B $0.02B 2.23
2018-12-31 $0.04B $0.03B 1.07
2018-09-30 $0.03B $0.04B 0.69
2018-06-30 $0.01B $0.05B 0.19
2018-03-31 $0.02B $0.06B 0.24
2017-12-31 $0.02B $0.07B 0.28
2017-09-30 $0.01B $0.08B 0.12
2017-06-30 $0.02B $0.09B 0.16
2017-03-31 $0.01B $0.03B 0.45
2016-12-31 $0.01B $0.04B 0.31
2016-09-30 $0.01B $0.05B 0.30
2016-06-30 $0.02B $0.03B 0.59
2016-03-31 $0.01B $0.04B 0.25
2015-12-31 $0.01B $0.05B 0.20
2015-09-30 $0.01B $0.05B 0.18
2015-06-30 $0.01B $0.06B 0.15
2015-03-31 $0.01B $0.07B 0.13
2014-12-31 $0.00B $0.08B 0.00
2014-09-30 $0.00B $0.09B 0.00
2014-06-30 $0.00B $0.09B 0.00
2014-03-31 $0.00B $0.10B 0.00
2013-12-31 $0.00B $0.11B 0.00
2013-09-30 $0.00B $0.12B 0.00
2013-06-30 $0.00B $0.05B 0.00
2013-03-31 $0.00B $0.05B 0.00
2012-12-31 $0.00B $0.06B 0.00
2012-09-30 $0.00B $0.06B 0.00
2012-06-30 $0.00B $0.07B 0.00
2012-03-31 $0.00B $0.03B 0.02
2011-12-31 $0.00B $0.03B 0.02
2011-09-30 $0.00B $0.04B 0.02
2011-06-30 $0.00B $0.04B 0.03
2011-03-31 $0.00B $0.02B 0.13
2010-12-31 $0.00B $0.02B 0.00
2010-09-30 $0.00B $0.02B 0.00
2010-06-30 $0.00B $0.03B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.326B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $122.872B 25.45
Intuitive Surgical (ISRG) United States $66.778B 52.48
Edwards Lifesciences (EW) United States $50.799B 46.13
IDEXX Laboratories (IDXX) United States $22.698B 54.90
Fresenius Medical Care AG KGaA (FMS) Germany $22.488B 15.22
Olympus (OCPNY) Japan $21.073B 158.26
DexCom (DXCM) United States $19.915B 178.34
Teleflex (TFX) United States $16.381B 33.26
Sysmex ADR (SSMXY) Japan $14.885B 40.07
SONOVA HOLDING (SONVY) Switzerland $14.154B 0.00
STERIS (STE) Ireland $12.878B 28.44
Hologic (HOLX) United States $12.603B 19.32
Varian Medical Systems (VAR) United States $11.699B 27.69
ABIOMED (ABMD) United States $8.324B 45.29
Masimo (MASI) United States $8.172B 48.80
Penumbra (PEN) United States $5.892B 191.78
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Globus Medical (GMED) United States $5.547B 34.23
Integra LifeSciences Holdings (IART) United States $5.059B 21.74
Elekta AB (EKTAY) Sweden $4.779B 36.79
Tandem Diabetes Care (TNDM) United States $3.944B 0.00
LivaNova (LIVN) United Kingdom $3.834B 27.60
Wright Medical Group (WMGI) Netherlands $3.755B 227.62
Nevro (NVRO) United States $3.248B 0.00
Cantel Medical (CMD) United States $3.080B 30.53
Integer Holdings (ITGR) United States $2.420B 16.57
Nihon Kohden (NHNKY) Japan $2.365B 23.79
Glaukos (GKOS) United States $2.281B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.584B 31.18
Inogen (INGN) United States $1.566B 49.43
Veracyte (VCYT) United States $1.268B 0.00
Silk Road Medical (SILK) United States $1.119B 0.00
Tactile Systems Technology (TCMD) United States $1.104B 126.15
Natus Medical (NTUS) United States $1.096B 26.35
OPKO Health (OPK) United States $1.018B 0.00
Mesa Laboratories (MLAB) United States $1.011B 37.48
CryoLife (CRY) United States $0.923B 94.61
Accelerate Diagnostics (AXDX) United States $0.908B 0.00
Luminex (LMNX) United States $0.892B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.854B 28.37
Pacific Biosciences Of California (PACB) United States $0.717B 0.00
Intersect ENT (XENT) United States $0.673B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.582B 0.00
AngioDynamics (ANGO) United States $0.572B 20.55
Quotient (QTNT) Switzerland $0.553B 0.00
Alphatec Holdings (ATEC) United States $0.447B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.441B 13.33
Si-Bone (SIBN) United States $0.437B 0.00
Sientra (SIEN) United States $0.394B 0.00
Semler Scientific (SMLR) United States $0.290B 39.09
ViewRay (VRAY) United States $0.288B 0.00
IRadimed (IRMD) United States $0.269B 37.74
Stereotaxis (STXS) United States $0.250B 0.00
SeaSpine Holdings (SPNE) United States $0.247B 0.00
Accuray (ARAY) United States $0.245B 0.00
CRH Medical (CRHM) Canada $0.208B 58.00
Fluidigm (FLDM) United States $0.161B 0.00
RTI Surgical (RTIX) United States $0.145B 39.20
EDAP TMS S.A (EDAP) France $0.141B 37.38
ConforMIS (CFMS) United States $0.124B 0.00
Second Sight Medical Products (EYES) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
Electromed (ELMD) United States $0.084B 30.21
T2 Biosystems (TTOO) United States $0.084B 0.00
Neuronetics (STIM) United States $0.077B 0.00
Vermillion (VRML) United States $0.071B 0.00
TransEnterix (TRXC) United States $0.064B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
Sensus Healthcare (SRTS) United States $0.059B 0.00
Bioanalytical Systems (BASI) United States $0.042B 0.00
Ekso Bionics Holdings (EKSO) United States $0.040B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.040B 0.00
Xtant Medical Holdings (XTNT) United States $0.024B 0.00
Neovasc (NVCN) Canada $0.021B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
Helius Medical Technologies (HSDT) United States $0.019B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.13
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Avinger (AVGR) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.013B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
DarioHealth (DRIO) Israel $0.009B 0.00
Restoration Robotics (VERO) Canada $0.009B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
Nuvectra (NVTR) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
InspireMD (NSPR) Israel $0.001B 0.00